These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 6223793

  • 1. In vitro activity of teichomycin against isolates of gram-positive bacteria.
    Fietta A, Bersani C, Mangiarotti P, Gialdroni Grassi G.
    Chemotherapy; 1983; 29(4):275-82. PubMed ID: 6223793
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of teichomycin A 2 in comparison with penicillin and vancomycin against gram-positive cocci.
    Bauernfeind A, Petermüller C.
    Eur J Clin Microbiol; 1982 Oct; 1(5):278-81. PubMed ID: 6223812
    [Abstract] [Full Text] [Related]

  • 3. Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics.
    Pallanza R, Berti M, Goldstein BP, Mapelli E, Randisi E, Scotti R, Arioli V.
    J Antimicrob Chemother; 1983 May; 11(5):419-25. PubMed ID: 6223907
    [Abstract] [Full Text] [Related]

  • 4. Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci.
    Tuazon CU, Miller H.
    Antimicrob Agents Chemother; 1984 Apr; 25(4):411-2. PubMed ID: 6233934
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of teichomycin compared with those of other antibiotics.
    Neu HC, Labthavikul P.
    Antimicrob Agents Chemother; 1983 Sep; 24(3):425-8. PubMed ID: 6227282
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD.
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of teichomycin and vancomycin alone and in combination with rifampin.
    Varaldo PE, Debbia E, Schito GC.
    Antimicrob Agents Chemother; 1983 Mar; 23(3):402-6. PubMed ID: 6221692
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the in vitro activities of teichomycin A2 and vancomycin against staphylococci and enterococci.
    Cynamon MH, Granato PA.
    Antimicrob Agents Chemother; 1982 Mar; 21(3):504-5. PubMed ID: 6213192
    [Abstract] [Full Text] [Related]

  • 9. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci].
    Bezian MC, Ribou G, Masquelier B.
    Pathol Biol (Paris); 1992 May; 40(5):461-5. PubMed ID: 1386667
    [Abstract] [Full Text] [Related]

  • 10. Comparative in vitro activity of teicoplanin and vancomycin against United States teicoplanin clinical trial isolates of gram-positive cocci.
    Kenny MT, Dulworth JK, Brackman MA.
    Diagn Microbiol Infect Dis; 1991 May; 14(1):29-31. PubMed ID: 1826479
    [Abstract] [Full Text] [Related]

  • 11. Microbiological properties of teicoplanin.
    Greenwood D.
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():1-13. PubMed ID: 2965119
    [Abstract] [Full Text] [Related]

  • 12. Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus.
    Tascini C, Flammini S, Leonildi A, Ciullo I, Tagliaferri E, Menichetti F.
    J Chemother; 2012 Aug; 24(4):187-90. PubMed ID: 23040680
    [Abstract] [Full Text] [Related]

  • 13. In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.
    Guenthner SH, Wenzel RP.
    Antimicrob Agents Chemother; 1984 Aug; 26(2):268-9. PubMed ID: 6237606
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of the new glycopeptide decaplanin.
    Neu HC, Chin NX, Niu WW.
    Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):458-62. PubMed ID: 1330562
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study.
    Karlowsky JA, Adam HJ, Poutanen SM, Hoban DJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):342-7. PubMed ID: 21353963
    [Abstract] [Full Text] [Related]

  • 16. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M, Hidalgo Orozco R, Rodríguez Garrido S, Gaona Álvarez C, Sánchez Silos RM, Hernández Rastrollo R, Martínez Tallo E, Cordero Carrasco JL.
    Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
    [Abstract] [Full Text] [Related]

  • 17. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
    Shibl AM, Ishag AH, Durgham SM.
    APMIS Suppl; 1988 Mar; 3():68-70. PubMed ID: 2972301
    [Abstract] [Full Text] [Related]

  • 18. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
    Thamlikitkul V.
    J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of LY264826, a new glycopeptide antibiotic, against gram-positive bacteria isolated from patients with cancer.
    Rolston KV, Nguyen H, Messer M.
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2137-41. PubMed ID: 2149921
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of dalbavancin against multidrug-resistant Staphylococcus aureus and streptococci from patients with documented infections in Europe and surrounding regions (2011-2013).
    Huband MD, Castanheira M, Farrell DJ, Flamm RK, Jones RN, Sader HS, Mendes RE.
    Int J Antimicrob Agents; 2016 Jun; 47(6):495-9. PubMed ID: 27211209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.